SUPRACOR

SUPRACOR™ - new excimer laser presbyopia procedure*

NOW CE MARKED!

SUPRACOR is a new corneal approach to treating presbyopia with TECHNOLAS Excimer Workstation 217P

The procedure is designed for the full refractive treatment range: hyperopia (CE Marked), myopia, post-cataract (Pseudophakic), post LASIK. The procedure provides excellent distance, intermediate and near vision, whilst maintaining a high quality of vision.
Combines the best of both worlds, using the growing INTRACOR experience and learnings from the corneal approach with excimer laser.
While other presbyopic algorithms create undesired aberrations inside the pupil region, SUPRACOR provides the near addition without inducing undesired aberrations.

* SUPRACOR is CE marked but NOT approved for use in the US. SUPRACOR is not approved in all countries. Please contact our regional representative regarding individual availability in your respective market.

Some of the products and/or specific features as well as the procedures featured on this website may not be approved in your country and thus may not be available there. The VICTUS platform has CE Marking for capsulotomy, lens fragmentation, arcuate corneal incisions, corneal incisions, LASIK flap, INTRACOR^®, penetrating keratoplasty and intrastromal channel incisions for intracorneal ring segments. Indications may vary by country. The VICTUS platform is cleared in the United States for creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea, anterior capsulotomy during cataract surgery, and arcuate incisions during cataract surgery.
SUPRACOR, INTRACOR, and CUSTOMSHAPE are CE marked but NOT approved for use in the US.
INTRACOR, SUPRACOR, CUSTOMSHAPE and CUSTOMFLAP are not approved in all countries. Please contact our regional representative regarding individual availability in your respective market.

CAREERS | IMPRINT & LEGAL STATEMENTS

A Bausch + Lomb Company